The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for CurvaFix sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
CurvaFix is a medical device company that develops a novel solution to unmet medical needs in orthopaedical trauma. It is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix IM implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis and provides a new state-of-art option for pelvic fracture repair. CurvaFix is headquartered in Bellevue, Washington, the US.
The key metrics of CurvaFix related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As CurvaFix is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as CurvaFix.
For a detailed understanding of the performance of CurvaFix, buy the report here.